Literature DB >> 14630205

Cytokines and autoimmunity: redundancy defines their complex nature.

Deepak Yadav1, Nora Sarvetnick.   

Abstract

Cytokines are critical mediators in autoimmunity and a better understanding of their mode of action should contribute to the development of strategies for controlling harmful autoimmune reactions. Their complicated nature makes it difficult to classify them as pro- or anti-inflammatory mediators; redundancy in their mode of action has been widely reported. Their complexity is further exemplified by the fact that several cytokines display redundancy in their receptor usage, with the recently identified IL-12 and IL-10 families being prototypical examples. Several aspects--including kinetics of expression, mode of induction, regulation of receptor expression and competition for occupancy, and the stage (acute vs chronic) of the disease--are critical to the net effect, and all these aspects need to be understood if we are to define a cytokine's whole nature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630205     DOI: 10.1016/j.coi.2003.09.006

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  8 in total

1.  Peritoneal macrophages suppress T-cell activation by amino acid catabolism.

Authors:  R Matlack; K Yeh; L Rosini; D Gonzalez; J Taylor; D Silberman; A Pennello; J Riggs
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

Review 2.  Protein array diagnostics for guiding therapy in rheumatoid arthritis.

Authors:  Peter Szodoray; Philip Alex
Journal:  Mol Diagn Ther       Date:  2011-10-01       Impact factor: 4.074

Review 3.  The NOD Mouse Beyond Autoimmune Diabetes.

Authors:  Anne-Marie Aubin; Félix Lombard-Vadnais; Roxanne Collin; Holly A Aliesky; Sandra M McLachlan; Sylvie Lesage
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

Review 4.  Regulation of autoimmune inflammation by pro-inflammatory cytokines.

Authors:  Eugene Y Kim; Kamal D Moudgil
Journal:  Immunol Lett       Date:  2008-08-09       Impact factor: 3.685

5.  Individual differences in pre-carcinogen cytokine and corticosterone concentrations and depressive-like behavior predict tumor onset in rats exposed to a carcinogen.

Authors:  Leah M Pyter; Brian J Prendergast
Journal:  Psychoneuroendocrinology       Date:  2012-10-06       Impact factor: 4.905

Review 6.  Chimerism and tetragametic chimerism in humans: implications in autoimmunity, allorecognition and tolerance.

Authors:  Edmond J Yunis; Joaquin Zuniga; Viviana Romero; Emilio J Yunis
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

7.  New Approaches to the Immunotherapy of Type 1 Diabetes Mellitus Using Interleukin-27.

Authors:  Fatemeh Zamani; Shohreh Almasi; Tohid Kazemi; Rana Jahanban Esfahlan; Mohammad Reza Aliparasti
Journal:  Adv Pharm Bull       Date:  2015-12-31

8.  CD28/CD154 blockade prevents autoimmune diabetes by inducing nondeletional tolerance after effector t-cell inhibition and regulatory T-cell expansion.

Authors:  Mark R Rigby; Alison M Trexler; Thomas C Pearson; Christian P Larsen
Journal:  Diabetes       Date:  2008-05-20       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.